Record #242461 - GSI Repository

LPT

LPT – Laser based Proton Therapy sysLPT – Laser based Proton Therapy system, Harnessing High Intensity Lasers Physics for Cancer Treatment Proton Therapy

Grant period	2020-12-01 - 2022-11-30
Funding body	European Union
Call number	H2020-EIC-FTI-2018-2020
Grant number	965586
Identifier	G:(EU-Grant)965586

Note: Cancer is a global problem with 14.1 million new cases occurring annually and an expected increase of 68% by 2030. Ensuring effective and safe treatment remains a significant challenge for healthcare organisations. Studies have shown proton therapy to be effective in treating many types of tumours, including tumours of the prostate, brain, head and neck, central nervous system, lung, and gastrointestinal system as well as cancers that cannot be removed completely by surgery. Proton therapy is the most advanced type of external-beam radiation therapy that uses protons at high energy to destroy cancer cells. Proton therapy is routinely used for cancer treatment however it is limited by the sheer size and expense of the systems. There are currently only 66 operational proton therapy facilities in the world, addressing only 3-5% of clinical demand. LPT is developing a proton therapy system that overcomes the presented challenges, saving up to 50% space and reducing costs by up to 75%. LPT applies a patented approach to particle acceleration and beam delivery, combining nanotechnology with Nobel- Prizewinning ultra-high-intensity lasers and advanced magnetics. These technological breakthroughs enable meaningful reduction in the size, complexity and cost of proton therapy systems that will enable the widespread adoption of proton therapy both across Europe and globally. The technology is supported by the Horizon 2020, SME instrument. The LPT project aims to take the innovation to the next level through the collaboration of strong industrial and academia players. Together, HIL applied medical, THALES Optronique and INFN, will achieve fundamental milestones in the development of the commercial system, namely PT-100. This system will be constructed based on the Alpha system (developed with the support of SME instrument), with a higher repetition rate and proton flux to enable clinical use and wide market adoption.

Recent Publications

There are no publications

Record created 2021-10-10, last modified 2023-02-12

Similar records

Add to personal basket
Export as Author List with IDs BibTeX (UTF-8), EndNote XML, EndNote Text, RIS, MARC, Print MARC, MARCXML, DC,
Request correction
Submit fulltext

GSI Homepage \| GSI Library \| English Deutsch \| guest :: login GSI Repository
Search	Submit	Personalize Your alerts Your baskets Your searches	Help